Gilead Sciences, Inc.
Multispecific antibodies that target HIV GP120 and CD3
Last updated:
Abstract:
Multispecific antibodies (e.g., bispecific antibodies) that bind to HIV gp120 and CD3 are disclosed. Also disclosed are methods of using such antibodies to treat or prevent HIV infection.
Status:
Grant
Type:
Utility
Filling date:
21 Jun 2018
Issue date:
5 Jan 2021